Remove 2025 Remove Pharma Remove Prescription
article thumbnail

Cigna's Express Scripts to cross out AbbVie's Humira from some formularies in 2025, opting to go with biosims instead

Fierce Pharma

When CVS Caremark removed AbbVie’s Humira from its national commercial formularies back in April, biosimilar prescriptions picked up at a whirlwind pace. Following CVS Caremark's lead, Cigna's pharmacy benefit manager unit will nix Humira from formularies in favor of Humira biosimilars from Boehringer Ingelheim, Teva and Sandoz.

article thumbnail

FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date

Fierce Pharma

The FDA assigned the subcutaneous Leqembi application a Prescription Drug User Fee Act decision date of January 25, 2025. About a month after Eisai initiated a rolling FDA application for its subcutaneous form of Leqembi, the U.S. agency has accepted the filing. |

FDA 241
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

billion in 2025. The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. from 2021 and reach $4.2

article thumbnail

4 Ways to Meet the Needs of an Increasing Health-conscious Audience

PM360

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer.

Retail 97
article thumbnail

Pistoia Alliance Survey Finds 85% of Life Science Professionals are Concerned About the Impact of Differing AI Regulations on Cross-Border Collaboration

Copyright Clearance Center

By standardizing the terminology used to describe substances, the Alliances IDMP Ontology will aid compliance, and enable safer cross-border prescriptions. The Pistoia Alliance is now welcoming registrations for its next member conference in London, 25-26 March 2025.

article thumbnail

The U.S. health insurance market is undergoing a post-pandemic sea change

Clarivate

After staying relatively flat for several years, enrollment growth took off in 2021 after an expansion in federal subsidies for silver-level plans passed in the American Rescue Plan and was then renewed through 2025 in the Inflation Reduction Act.

article thumbnail

Diagnostics Market Expectations and Opportunities Post Pandemic

PM360

This has led to significant changes in the healthcare diagnostics market and has created new opportunities and challenges for pharma executives. The data from these devices can help facilitate those treatment changes like the prescription required for a continuous glucose monitor for consumers.